Dechra Pharmaceuticals

About Dechra Pharmaceuticals

Dechra Pharmaceuticals is a global leader in the veterinary pharmaceutical industry, dedicated to improving the health and well-being of animals. Founded in 1997, the company has established a strong presence in the UK and internationally, focusing on the development, manufacture, and marketing of high-quality veterinary products.

With a commitment to innovation, Dechra invests significantly in research and development to create effective solutions for veterinarians and pet owners. The company’s product portfolio includes a wide range of pharmaceuticals, including anti-infectives, analgesics, and dermatological treatments, tailored specifically for various animal species.

Dechra’s vision is to be the most trusted partner in veterinary medicine, providing exceptional service and support to its customers. The company prides itself on its ethical practices and dedication to sustainability, ensuring that its operations have a positive impact on the environment and society.

In addition to its core pharmaceutical offerings, Dechra also provides a variety of services, including training and educational resources for veterinary professionals. This holistic approach ensures that veterinarians are equipped with the knowledge and tools necessary to provide the best care for their patients.

As a publicly traded company on the London Stock Exchange, Dechra continues to grow and expand its global footprint, with a focus on strategic acquisitions and partnerships. The company’s commitment to quality and excellence has earned it a reputation as a trusted name in veterinary medicine.

Overall, Dechra Pharmaceuticals is not just a manufacturer of veterinary products; it is a partner in the journey towards better animal health, driven by a passion for innovation and a deep understanding of the needs of the veterinary community.